ATS 2022: Tezepelumab Therapy Improved Severe Asthma in Half of Patients
Prespecified exploratory analysis shows durable response of tezepelumab for lung function, asthma control, and exacerbation reduction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.